ISMB 99: Program Committee

Ruben Abagyan, Skirball Institute of Biomolecular Medicine, New York, NY, USA
Tatsuya Akutsu, Human Cenome Center, Tokyo, Japan
Lloyd Allison, Monash University, Australia
Russ Altman, Stanford University, CA, USA
Stephen Altschul, National Center for Biotechnology Information, Bethesda, MD, USA
Michael Ashburner, European Bioinformatics Institute, Cambridge, UK
Bonnie Berger, Massachusetts Institute of Technology, Cambridge, MA, USA
Soren Brunak, The Technical University of Denmark, Lyngby, Denmark
Barbara Bryant, Millennium Pharmaceuticals, Cambridge, MA, USA
Steve Bryant, National Center for Biotechnology Information, Bethesda, MD, USA
Philip Bucher, University of Geneva, Geneva, Switzerland
Antoine Danchin, Institut Pasteur, Paris, France
Valentina Di Francesco, Celera Genomics Corp., Rockville, MD, USA
Sean Eddy, Washington University, St. Louis, MO, USA
Jacquelyn S. Fetrow, State University of New York, Albany, NY, USA
Dimitrij Frishman, Munich Information Centre for Protein Sequence, Martinsried, Germany
Terry Gaasterland, Rockefeller University, New York, NY, USA
Michael Gribskov, San Diego Supercomputer Center, La Jolla, CA, USA
David Haussler, University of California, Santa Cruz, CA, USA
Liisa Holm, European Bioinformatics Institute, Cambridge, UK
Martin Huynen, European Molecular Biology Laboratory, Heidelberg, Germany
Minoru Kanehisa, Kyoto University, Japan
Peter Karp, Pangea Systems, Inc., Oakland, CA, USA
Kevin Karplus, University of California, Santa Cruz, CA, USA
Toni Kazic, Washington University, St. Louis, MO, USA
Teri Klein, University of California, San Francisco, CA, USA
John Koza, Stanford University, CA, USA
Alan Lapedes, Santa Fe Institute, NM, USA
Rick Lathrop, University of California, Irvine, CA, USA
Claudine Medigue, Universite Paris VI, France
Gene Myers, Celera Genomics Corp., Rockville, MD, USA
Christos Ouzounis, European Bioinformatics Institute, Cambridge, UK
Christian Overton, University of Pennsylvania, Philadelphia, PA, USA
Rebecca Parsons, University of Central Florida, Orlando, FL, USA
Christopher Rawlings, Smithkline Beecham Pharmaceuticals, Harlow, UK
Burkhard Rost, Columbia University, New York, NY, USA
Steven Salzberg, Johns Hopkins University, Rockville, MD, USA
David Searls, SmithKline Beecham Pharmaceuticals, King of Prussia, PA, USA
Jude Shavlik, University of Wisconsin, Madison, WI, USA
Gary Stormo, University of Colorado, Boulder, CO, USA
Joel Sussman, Weizmann Institute of Science, Rehovot, Israel
William Taylor, MRC National Institute of Medical Research, London, UK
Anna Tramontano, Department of Computational Biology and Chemistry, IRBM, Pomezia, Italy
Alfonso Valencia, CNB-Centro Nacional de Bio./CSIC-Spanish Research Council, Madrid, Spain
Martin Vingron, DKFZ - German Cancer Research Center, Heidelberg, Germany
Edgar Wingender, GBF - German National Research Center for Biotechnology, Braunschweig, Germany
Thomas Wu, Stanford University, CA, USA

 

-> ISMB 99